Pooled medians for the diagnostic interval as a function of country socioeconomic indicators.

dataset

posted on 2022-10-20, 18:04 authored by Dafina Petrova, Zuzana Špacírová, Nicolás Francisco Fernández-Martínez, Ana Ching-López, Dunia Garrido, Miguel Rodríguez-Barranco, Marina Pollán, Daniel Redondo-Sánchez, Carolina Espina, Camila Higueras-Callejón, Maria José Sánchez

Note: k = number of studies/estimates; N = number of patients; med = pooled median; LLCI and ULCI = lower level and upper level confidence interval, respectively; Difference = pooled median for high-income countries minus pooled median for lower-income countries; Breast cancer excludes pregnancy-associated breast cancer; p = p-value from a moderator test in a random-effects model, *<0.05, **<0.01, ***<0.001; R² = percentage of variance in the outcome explained by the moderator. When k = 1, the median from the single located study is reported.

(XLSX)

History

Usage metrics

Categories

Keywords

g ., prostate g ., myelomas g ., cervical considered core indicators 77 ], e 67 ], e 66 ], e 54 ], e 4 times longer 108 ]) cancers primary symptomatic cancer 85 ], e many possible biases income countries (<g ., colorectal treatment start ).78 ])) cancers treatment intervals came cancer treatment pathway adult patients diagnosed 145 ])), genitourinary studies conducted worldwide longest treatment intervals longest diagnostic intervals articles reported data analysis income countries treatment intervals seeking times n eligible articles cis ).adult patients 87 ]))112 ])),treatment interval 85 days following intervals diagnostic intervals confidence intervals neck cancer cancer sites xlink ">worse survival various types time points three databases systematic review survivor bias study medians review estimated results identify reduce help proquest dissertations pooled estimate methodological quality large number inherent complexity google scholar global disparities first presentation directed policies diagnostic interval consistently 1 ci 52 assessed using 72 %),594 patients

Licence

Exports